Carnosine

Category
metabolite
Routes
Oral (PO)
Half-Life (t½)
PO: 1m
Formula
C9H14N4O3
Molecular Weight
226.23 g/mol
PubChem CID
439224
Aliases
β-Alanyl-L-histidine, L-Carnosine

Pharmacological Mechanism

β-Alanyl-L-histidine dipeptide, highly concentrated in fast-twitch skeletal muscle (~20–40 mmol/kg dry weight) and olfactory bulb. Intramuscular roles: proton buffer (pKa 6.83 — ideal for pH-drop during high-intensity contraction), reactive carbonyl / metal ion chelator, and pH-independent Ca²⁺ sensitiser in myofibrils. Orally, intact carnosine is rapidly cleaved by serum carnosinase (CN1/CNDP1) and tissue carnosinase (CN2) to β-alanine + histidine within minutes of absorption. Therefore oral carnosine itself is a poor way to raise muscle carnosine — oral β-alanine is the rate-limiting precursor and the evidence-based route.

Half-Life & Elimination Curve (PO: 1m)

100%50%25%12.5%0%0h0×t½1m1×t½2m2×t½4m3×t½5m4×t½6m5×t½0×t½ (0h): 100% remaining (~0.115 mg/L)1×t½ (1m): 50% remaining (~57.7 µg/L)2×t½ (2m): 25% remaining (~28.8 µg/L)3×t½ (4m): 12.5% remaining (~14.4 µg/L)4×t½ (5m): 6.3% remaining (~7.21 µg/L)5×t½ (6m): 3.1% remaining (~3.61 µg/L)
Plasma (PO)t½ Decay (1m)
  • 0×t½0h100% (0.115 mg/L)
  • 1×t½1m50% (57.7 µg/L)
  • 2×t½2m25% (28.8 µg/L)
  • 3×t½4m12.5% (14.4 µg/L)
  • 4×t½5m6.3% (7.21 µg/L)
  • 5×t½6m3.1% (3.61 µg/L)
Elimination t½1m (PO)
Rate Constant (ke)34.7 h⁻¹
Time to Peak (Tmax)5m
Est. Peak (Cmax)0.115 mg/L
Clearance (CL)728 L/h
97% Washout (5×t½)6m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References